Drug: TYSABRI Injury: Multiple sclerosis Quarter: 2016Q3
Total Records: 77 Number of Pages: 4
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125228651 | TYSABRI | Multiple sclerosis | BIOGEN | 58.54 YR | M | 0 | 20160701 | US |
125231081 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160701 | US |
125233411 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160702 | US |
125348931 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160707 | US |
125412561 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160708 | US |
125432952 | TYSABRI | Multiple sclerosis | TEVA | 31.69 YR | M | 68 KG | 20160801 | US |
125477411 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160712 | US |
125505962 | TYSABRI | Multiple sclerosis | BIOGEN | 27.40 YR | F | 0 | 20160907 | US |
125515241 | TYSABRI | Multiple sclerosis | BIOGEN | 30.04 YR | M | 0 | 20160713 | US |
125517571 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160713 | US |
125524352 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160729 | GB |
125533071 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160713 | US |
125583883 | TYSABRI | Multiple sclerosis | BIOGEN | 46.34 YR | F | 0 | 20160810 | US |
125593151 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160715 | US |
125643711 | TYSABRI | Multiple sclerosis | BIOGEN | 41.48 YR | F | 0 | 20160718 | US |
125703833 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160815 | US |
125759723 | TYSABRI | Multiple sclerosis | BIOGEN | 29.57 YR | F | 0 | 20160812 | CA |
125783001 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160721 | US |
125894561 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | M | 0 | 20160725 | CZ |
125903021 | TYSABRI | Multiple sclerosis | BIOGEN | 0.00 | F | 0 | 20160725 | US |
Total Records: 77 Number of Pages: 4